Verteporfin: a milestone in opthalmology and photodynamic therapy

Expert Opinion on Pharmacotherapy
S B Brown, K J Mellish

Abstract

During the past year, a photosensitiser named benzoporphyrin derivative (BPD) has been approved in 26 countries under the generic name verteporfin (Visudynetrade mark, Novartis), for the treatment of patients with a certain type of the wet form of age-related macular degeneration (AMD) by photodynamic therapy (PDT). AMD is the leading cause of blindness in the developed world, with approximately half a million new cases of the wet form per year. The approval of Visudynetrade mark therapy represents a major milestone in ophthalmology since AMD was previously untreatable by any modality which would preserve existing vision. It was also a milestone in the development of PDT, not only because it represented the first breakthrough in the use of PDT to treat an otherwise untreatable condition, but also because it represented the first mass market for a PDT treatment where prospects of a substantial financial return on many years of investment appear to be likely. In this article, we look at the background to the development of BPD, primarily for its use in AMD, but also in other applications.

References

Jun 1, 1987·Photochemistry and Photobiology·T J Dougherty
Jun 15, 1993·American Journal of Ophthalmology·K B FreundJ A Sorenson
Mar 1, 1994·Photochemistry and Photobiology·B AvelineR W Redmond
Mar 1, 1994·Photochemistry and Photobiology·A M RichterJ G Levy
Aug 1, 1994·Clinical Immunology and Immunopathology·R K ChowdharyJ G Levy
Mar 17, 1993·Journal of the National Cancer Institute·H I Pass
May 29, 1998·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·U Schmidt-ErfurthN M Bressler
Oct 26, 1999·Drug Discovery Today·W M Sharman van Lier JE
Nov 4, 2000·Expert Opinion on Investigational Drugs·D W Hunt, A H Chan
Jan 5, 2001·Expert Opinion on Investigational Drugs·S B BrownD I Vernon
Jul 5, 2005·Expert Opinion on Investigational Drugs·D W Hunt, J G Levy

❮ Previous
Next ❯

Citations

Mar 7, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Angeles JuarranzSalvador González
Mar 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Bin ChenTayyaba Hasan
Jun 28, 2011·Nature Reviews. Drug Discovery·David C Swinney, Jason Anthony
Jul 25, 2007·Photochemistry and Photobiology·Marino A CampoNorbert Lange
Sep 21, 2007·Photochemistry and Photobiology·Sarika VermaTayyaba Hasan
Jun 6, 2007·Antimicrobial Agents and Chemotherapy·Beth Burgwyn FuchsEleftherios Mylonakis
May 20, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Meltem Demirel KarsHamdi Şükür Kılıç
Jan 20, 2007·Biomedical Chromatography : BMC·H A IsakauP T Petrov
Aug 4, 2004·The Lancet Oncology·Stanley B BrownIan Walker
Oct 26, 2005·Chemistry & Biology·George P TegosMichael R Hamblin
Jul 31, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·María García-DíazMichael R Hamblin
Nov 18, 2010·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·David Phillips
Mar 1, 2005·Photodiagnosis and Photodynamic Therapy·Angelika RückRudolf Steiner
Mar 17, 2018·Journal of Ophthalmology·María Pilar Ruiz-Del-TiempoOscar Ruiz-Moreno
Sep 23, 2009·IEEE Transactions on Bio-medical Engineering·Arisa ItoTsunenori Arai
Apr 30, 2010·Physical Chemistry Chemical Physics : PCCP·Elisabetta ColliniSimone Silvestrini
Nov 27, 2019·Photochemistry and Photobiology·Daniel KrausBin Chen
Sep 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hui Shan LiewMay Lee Low
May 24, 2008·International Journal of Cancer. Journal International Du Cancer·Bin ChenBrian W Pogue
Nov 13, 2020·Frontiers in Pharmacology·Changran Wei, Xiangqi Li
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bin ChenTayyaba Hasan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.